Inventor
Frank Bergmann
Inventor
Iffeldorf, DE
Overview
Patents· 43 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms24%
C07HSugars19%
C12NMicroorganisms or enzymes11%
G01NInvestigating or analysing materials by determining their chemical or physical properties10%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
Y02PClimate change mitigation technologies in the production or processing of goods5%
C07KPeptides4%
C09KMaterials for miscellaneous applications, not provided for elsewhere4%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture3%
C12YEnzymes3%
PatentTitleYear
11,054,425System and method for identification and characterization of transglutaminase species202110,975,426Polypeptide tagged nucleotides and use thereof in nucleic acid sequencing by nanopore detection202110,788,495System and method for identification and characterization of transglutaminase species202010,640,815Set of oligonucleotide probes as well as methods and uses thereto202010,557,135Sequence tags202010,041,134Dual probe assay for the detection of HCV201810,006,915System and method for identification and characterization of transglutaminase species20189,963,737Dual probe assay for the detection of heterogeneous amplicon populations20189,834,765Sequence tags20179,719,133'Qualitative and quantitative detection of microbial nucleic acids'20179,611,505'Application of oligo-DT molecules to avoid generation of high molecular PCR products induced by poly-A carrier'20179,512,494'Dual probe assay for the detection of HCV'20169,499,573'Iridium-based complexes for ECL'20169,447,476'Method for preventing high molecular weight products during amplification'20169,416,150'Iridium-based complexes for ECL'20169,410,197'Compound for sequencing by synthesis'20169,403,859'Iridium-based complexes for ECL'20169,399,654'Iridium-based complexes for ECL'20169,347,091'Set of oligonucleotide probes as well as methods and uses thereto'20168,877,464'Qualitative and quantitative detection of microbial nucleic acids'20148,445,206'Set of oligonucleotide probes as well as methods and uses thereto'20138,350,038'Fluorescence quencher molecules'20138,124,338'Use of TDE for isolation of nucleic acids'20128,062,843'Use of acetals for isolation of nucleic acids'20118,057,997'Nucleic acid binding compounds containing pyrazolo[3,4-D]pyrimidine analogues of purin-2,6-diamine and their uses'20117,989,169'Selective amplification of methylated nucleic acids'20117,847,075'2-Azapurine compounds and their use'20107,781,165'Benzimidazolium compounds and salts of benzimidazolium compounds for nucleic acid amplification'20107,759,470'Labeling reagent'20107,612,187'2-azapurine compounds and their uses'20097,566,775'N8- and C8-linked purine bases and structurally related heterocycles as universal nucleosides used for oligonucleotides hybridization'20097,560,231'Mannitol and glucitol derivatives'20097,413,855'Method for bisulfite treatment'20087,329,491'Methods for isolating nucleic acids'20087,276,592'Nucleotide analogs with six-membered rings'20077,238,795'Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses'20077,169,553'2-Azapurine compounds and their use'20077,063,945'N8 -and c8 -linked purine based and structurally related heterocycles as universal nucleosides used oligonucleotides hybridization'20066,388,061'Monomeric building blocks for labeling peptide nucleic acids'20026,235,476'Process for detecting nucleic acids by mass determination'20016,048,975'Process for the chemical synthesis of oligonucleotides'20005,945,524'Process for the chemical synthesis of oligonucleotides'19995,631,362'5\'-O-Dans EOC modified nucleosides and methods for preparing same'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2000Based in Weissenberg, DE· patent location history
2001–2021Based in Iffeldorf, DE· patent location history
2006–2021Patents assigned to ROCHE MOLECULAR SYSTEMS INC (19)· patent assignee history
2007–2013Patents assigned to ROCHE DIAGNOSTICS OPERATIONS (8)· patent assignee history
2011–2016Patents assigned to BERGMANN FRANK (7)· patent assignee history
2016–2017Patents assigned to ROCHE DIAGNOSTICS OPERATIONS INC (6)· patent assignee history
2018–2021Patents assigned to ROCHE SEQUENCING SOLUTIONS INC (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ROCHE MOLECULAR SYSTEMS INC | 19 | 2006–2021 |
| ROCHE DIAGNOSTICS OPERATIONS | 8 | 2007–2013 |
| BERGMANN FRANKself | 7 | 2011–2016 |
| ROCHE DIAGNOSTICS OPERATIONS INC | 6 | 2016–2017 |
| ROCHE SEQUENCING SOLUTIONS INC | 5 | 2018–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Iffeldorf, DE | 40 | 2001–2021 |
| Weissenberg, DE | 3 | 1997–2000 |